The place of the botulinum toxin in the management of multiple sclerosisHABEK, Mario; KARNI, Arnon; BALASH, Yakov et al.Clinical neurology and neurosurgery (Dutch-Flemish ed.). 2010, Vol 112, Num 7, pp 592-596, issn 0303-8467, 5 p.Conference Paper

The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease : A double blind placebo-controlled pilot studyGUREVICH, Tanya; PERETZ, Chava; MOORE, Orna et al.Movement disorders. 2007, Vol 22, Num 6, pp 880-883, issn 0885-3185, 4 p.Article

Parkinson's disease: Before the motor symptoms and beyondKORCZYN, Amos D; GUREVICH, Tanya.Journal of the neurological sciences. 2010, Vol 289, Num 1-2, pp 2-6, issn 0022-510X, 5 p.Conference Paper

Homozygosity for the MTX1 c.184T>A (p.S63T) alteration modifies the age of onset in GBA-associated Parkinson's diseaseGAN-OR, Ziv; BAR-SHIRA, Anat; GUREVICH, Tanya et al.Neurogenetics (Oxford. Print). 2011, Vol 12, Num 4, pp 325-332, issn 1364-6745, 8 p.Article

Association of Sequence Alterations in the Putative Promoter of RAB7L1 With a Reduced Parkinson Disease RiskGAN-OR, Ziv; BAR-SHIRA, Anat; DAHARY, Dvir et al.Archives of neurology (Chicago). 2012, Vol 69, Num 1, pp 105-110, issn 0003-9942, 6 p.Article

Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopaSCHAAFSMA, Joanna D; GILADI, Nir; BALASH, Yacov et al.Journal of the neurological sciences. 2003, Vol 212, Num 1-2, pp 47-53, issn 0022-510X, 7 p.Article

Lower cognitive performance in healthy G₂019S LRRK2 mutation carriersTHALER, Avner; MIRELMAN, Anat; GUREVICH, Tanya et al.Neurology. 2012, Vol 79, Num 10, pp 1027-1032, issn 0028-3878, 6 p.Article

Red Flags for Multiple System AtrophyKÖLLENSPERGER, Martin; GESER, Felix; PELLECCHIA, Maria Teresa et al.Movement disorders. 2008, Vol 23, Num 8, pp 1093-1099, issn 0885-3185, 7 p.Article

Balance and gait in older adults with systemic hypertensionHAUSDORFF, Jeffrey M; HERMAN, Talia; BALTADJIEVA, Rossitza et al.The American journal of cardiology. 2003, Vol 91, Num 5, pp 643-645, issn 0002-9149, 3 p.Article

Effects of cognitive function on gait and dual tasking abilities in patients with Parkinson's disease suffering from motor response fluctuationsPLOTNIK, Meir; DAGAN, Yaacov; GUREVICH, Tanya et al.Experimental brain research. 2011, Vol 208, Num 2, pp 169-179, issn 0014-4819, 11 p.Article

Cerebral vasomotor reactivity in parkinson's disease, multiple system atrophy and pure autonomic failureGUREVICH, Tanya; GUR, Alexander Y; BORNSTEIN, Natan M et al.Journal of the neurological sciences. 2006, Vol 243, Num 1-2, pp 57-60, issn 0022-510X, 4 p.Article

Clinical characteristics of elderly patients with a cautious gait of unknown originGILADI, Nir; HERMAN, Talia; REIDER-GROSWASSER, Irith I et al.Journal of neurology. 2005, Vol 252, Num 3, pp 300-306, issn 0340-5354, 7 p.Article

Effect of rivastigmine on tremor in patients with Parkinson's disease and dementiaGUREVICH, Tanya Y; SHABTAI, Herzel; KORCZYN, Amos D et al.Movement disorders. 2006, Vol 21, Num 10, pp 1663-1666, issn 0885-3185, 4 p.Article

Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriersTHALER, Avner; MIRELMAN, Anat; GILADI, Nir et al.Cortex (Testo stampato). 2013, Vol 49, Num 9, pp 2501-2511, issn 0010-9452, 11 p.Article

Fighting the risk of developing Parkinson's disease; clinical counseling for first degree relatives of patients with Parkinson's diseaseGILADI, Nir; MIRELMAN, Anat; THALER, Avner et al.Journal of the neurological sciences. 2011, Vol 310, Num 1-2, pp 17-20, issn 0022-510X, 4 p.Article

The p.L302P mutation in the lysosom enzyme gene SMPD1 is a risk factor for Parkinson diseaseGAN-OR, Ziv; OZELIUS, Laurie J; GUREVICH, Tanya et al.Neurology. 2013, Vol 80, Num 17, pp 1606-1610, issn 0028-3878, 5 p.Article

Gait Alterations in Healthy Carriers of the LRRK2 G2019S MutationMIRELMAN, Anat; GUREVICH, Tanya; GILADI, Nir et al.Annals of neurology. 2011, Vol 69, Num 1, pp 193-197, issn 0364-5134, 5 p.Article

Can an accelerometer enhance the utility of the Timed Up & Go Test when evaluating patients with Parkinson's disease?WEISS, Aner; HERMAN, Talia; PLOTNIK, Meir et al.Medical engineering & physics. 2010, Vol 32, Num 2, pp 119-125, issn 1350-4533, 7 p.Article

Presentation, Diagnosis, and Management of Multiple System Atrophy in Europe: Final Analysis of the European Multiple System Atrophy RegistryKÖLLENSPERGER, Martin; GESER, Felix; KLOCKGETHER, Thomas et al.Movement disorders. 2010, Vol 25, Num 15, pp 2604-2612, issn 0885-3185, 9 p.Article